Hair Restoration ยท Oral tablet, women 45+
Ivy Hair Tablet
A once-daily tablet combining dutasteride, oral minoxidil and biotin, for women experiencing pattern thinning after menopause, when estrogen's protective effect on the follicle declines.
This is a compounded preparation made by a licensed pharmacy. It is not FDA-approved, and it is prescribed only when a licensed provider determines it is appropriate for you.
Already know this is what you want? The second option books the appointment straight away. Not sure yet? See the labs first.
Your consult is free. We will not prescribe this, or anything, before a clinician has spoken with you. Final cost depends on the form and dose prescribed.
Mechanism
Built for post-menopausal thinning.
Dutasteride is a more potent 5-alpha-reductase inhibitor than finasteride, blocking both major forms of the enzyme that converts testosterone into DHT. It is prescribed off-label for androgenic thinning in women, most often after menopause when estrogen's protective effect on the follicle declines.
Oral minoxidil widens blood vessels around the follicle and extends the hair cycle's growth phase, and biotin supports the keratin production hair is built from.
This combination is formulated specifically for women over 45; it is not the same prescription used for men, and dosing is set by your clinician based on your history and labs.
Safety and eligibility
Your consult and labs screen for all of the following.
- Pregnancy warning, Not for use during pregnancy, or if you are trying to become pregnant.
- Not for premenopausal thinning, driven primarily by androgen excess, where Willow Hair Tablet is typically a better fit, your clinician will confirm which applies to you.
- Fluid retention, oral minoxidil can occasionally cause swelling or a faster resting heart rate.
- Not FDA-approved for this exact combination, prescribed off-label, at your provider's discretion.
FAQ
Ivy Hair Tablet questions.
Dutasteride blocks both forms of the enzyme that produces DHT, and is the more commonly studied off-label option for post-menopausal androgenic thinning.
Willow Hair Tablet is formulated for women under 45 with a different hormonal driver; your clinician will help you choose the right one.
Tell your clinician your menopausal status; this formulation is intended for post-menopausal thinning specifically.
Judge at four to six months of consistent daily use, with a baseline photo.
We will not prescribe before we understand you.
Book a one-to-one consult with the clinical team. We talk through your goals, order the bloodwork that matters, and build a plan from what we find.